Evidence map›Paper›PMID 31600182›Full record

ArticleMMWR. Morbidity and mortality weekly report2019

Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.

Scott Epperson, C Todd Davis, Lynnette Brammer, Anwar Isa Abd Elal, Noreen Ajayi, John Barnes, Alicia P Budd, Erin Burns, Peter Daly, Vivien G Dugan and 13 more

Abstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  9. Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  15. Article
  16. Investigation of HumanFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Scott EppersonInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
C Todd DavisInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lynnette BrammerInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Anwar Isa Abd ElalInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Noreen AjayiInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
John BarnesInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alicia P BuddInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Erin BurnsInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Peter DalyInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Vivien G DuganInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alicia M FryInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Yunho JangInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sara Jo JohnsonInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Krista KnissInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rebecca KondorInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lisa A GrohskopfInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Larisa GubarevaInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Angiezel Merced-MoralesInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wendy SessionsInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
James StevensInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
David E WentworthInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xiyan XuInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Daniel JerniganInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During May 19-September 28, 2019,* low levels of influenza activity were reported in the United States, with cocirculation of influenza A and influenza B viruses. In the Southern Hemisphere seasonal influenza viruses circulated widely, with influenza A(H3) predominating in many regions; however, influenza A(H1N1)pdm09 and influenza B viruses were predominant in some countries. In late September, the World Health Organization (WHO) recommended components for the 2020 Southern Hemisphere influenza vaccine and included an update to the A(H3N2) and B/Victoria-lineage components. Annual influenza vaccination is the best means for preventing influenza illness and its complications, and vaccination before influenza activity increases is optimal. Health care providers should recommend vaccination for all persons aged ≥6 months who do not have contraindications to vaccination (1).

Indexed as

Population SurveillanceDrug Resistance, ViralGlobal HealthHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesSeasonsUnited StatesInfluenza Vaccines

Identifiers

PMID31600182
PMCPMC6788403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.